Morning Brief — Monday, September 7, 2026

Market Overview

Friday’s blowout August jobs report (162K vs. 56K est.) rattled rate-cut expectations and sent the S&P and Dow lower, though chipmaker strength kept the Nasdaq afloat. Today the AI infrastructure trade is back in focus — SNDK’s S&P 100 inclusion, CBRS’s $25B backlog story, and MRVL’s connectivity rally are all pointing to continued broadening of the AI trade beyond NVIDIA. The macro overhang from a potential Bank of Japan rate move and lingering rate-hike fears keeps the backdrop choppy, but sector rotation into semis and energy tech is the dominant theme.

Claude’s Call

UP — The post-jobs selloff in the S&P looks like an overreaction to a single data point; chipmakers are providing meaningful index support today and S&P 500 inclusion-driven buying in BE, ILMN, and SNDK adds mechanical upward pressure. Expect a modest recovery session, +0.3–0.6% on the S&P, led by tech and energy, with financials as a drag given the higher-rates narrative.

Top Movers

NX (+22.2%) — $22.93 → $24.99 (+9.0% upside) Thesis: Clean earnings beat — Q3 non-GAAP EPS of $0.79 came in 20.2% above consensus, revenue grew 1.3% YoY to $501.8M, and the company swung from a net loss of $6.04/share to +$0.58 — a massive profitability inflection. Management showed real cost discipline in a soft housing market, which is the real story here: they squeezed margin expansion out of a tough macro. The stock is at its 6-month high right now with volume running 5.5x average — that’s genuine institutional conviction, not a fluke. Levels: Exit at Fib 1.272 extension $24.99. Support at Fib 23.6% retracement $21.14, then $20.03.

Honest take: This move has legs on a 1-2 week basis — the fundamental turn is real. But at the 6-month high with no SMA overhead resistance data to anchor against, don’t chase aggressively above $23.50. The 22% single-day surge prices in much of the good news.

BLTE (+13.2%) — $193.61 → $209.57 (+8.2% upside) Thesis: FDA accepted the NDA for tinlarebant (Stargardt disease) with Priority Review and set a Feb. 12, 2027 PDUFA date — this is a concrete regulatory milestone, not speculation. Priority Review means the FDA sees real unmet medical need. The stock is at its 6-month high after a 27.6% week, with volume at 3.6x average confirming the move. Note Tarsus (TARS) is also in the Stargardt race after its Alkeus acquisition — competition risk is real but BLTE has the FDA runway advantage right now. Levels: Exit at Fib 1.272 extension $209.57. Support at Fib 23.6% retracement $179.76.

Honest take: One analyst has flagged it as “fully valued” after a 431% three-year run, and the forward P/E at 100x vs. a peer median of 15.5x is hard to justify unless tinlarebant gets approved. This is a binary regulatory bet dressed up as a momentum trade — size accordingly and respect the $179 support as your stop reference.

SNDK (+11.9%) — $1,740.00 → $2,826.69 (+62.5% to Fib 1.272) Thesis: S&P 100 inclusion is the mechanical catalyst today — index rebalancing forces passive funds to buy, and this is a forced, non-discretionary bid. Beyond that, the AI storage trade thesis is compelling: SNDK has reportedly locked more than half its output into contracted pricing, structurally reducing the memory-crash risk that has historically wrecked this sector. RSI at 61.2 is not yet overbought. The stock is recapturing the $1,644 Fib 38.2% support level from below, which is technically constructive. Levels: Exit at 20-day high $1,786.85 near-term, then Fib 23.6% retracement at $1,908. SMA-50 at $1,550 is the key support floor.

Honest take: The S&P 100 inclusion is real and the storage thesis is genuinely differentiated. The 6-month high is $2,335 — there’s room. But note the stock is still 25% off its 6-month high and the fib structure suggests resistance at $1,908. The contract-pricing story needs confirmation in next earnings — don’t hold through that without knowing the details.

CBRS (+10.3%) — $210.05 → $222.97 (+6.1% upside near-term) Thesis: $25.4 billion backlog with a single OpenAI agreement driving a massive chunk of it — that’s 29x forward revenue, which is extraordinary visibility for an AI infrastructure name. Coatue just disclosed a new position in Q2, adding institutional credibility. The 165MW Finland data center deal signals execution, not just bookings. RSI at neutral 50 and price sitting at $210 vs. the SMA-50 of $203 suggests this bounce has room. Levels: Exit near Fib 61.8% retracement $222.97. Next resistance at $239.80 (Fib 50%). Hard stop at SMA-50 $203.

Honest take: The backlog is real but concentration risk is extreme — if the OpenAI relationship changes, so does the entire thesis. Forward P/E of 165x vs. a 17.5x peer median is expensive even adjusting for 74% revenue growth. This is a traders’ stock, not an investor’s stock at this price. Ride the momentum but keep a tight leash.

BE (+7.4%) — $252.87 → $259.39 (+2.6% near-term) / $292.43 (+15.6% extended) Thesis: Bloom Energy’s S&P 500 inclusion (effective Sept. 21) is a confirmed, hard catalyst — this isn’t speculation, it’s index mechanics. Every passive fund tracking the S&P 500 must buy. On top of that, the AI energy narrative is gaining serious traction, and the Pelosi buy at the lows adds retail attention. The stock has cleared its SMA-50 at $226.48 decisively. Levels: Exit at Fib 38.2% retracement $259.39 near-term; extended target Fib 23.6% at $292.43. Support at SMA-50 $226.48, then the prior $205.97 Fib 61.8%.

Honest take: S&P 500 inclusion is one of the cleanest mechanical catalysts in markets — buying pressure is predictable and front-runnable. The AI energy angle gives it staying power beyond the index rebalancing date. Legitimate setup. The Pelosi angle is noise — don’t anchor to that.

MRVL (+7.1%) — $223.55 → $259.54 (+16.1% upside) Thesis: Pure AI connectivity broadening trade — investors are rotating from pure-play accelerators (NVDA) into the picks-and-shovels connectivity layer. Marvell raised its annual outlook on Aug. 27, and the stock’s pullback to $206 last week now looks like an overreaction to the Google-revenue timing concern (material contribution not until FY2029). Today’s bounce from near the Fib 38.2% support at $224.39 is textbook — price found the level and bounced. Levels: Exit at 20-day high $251.01 first, then Fib 23.6% resistance $259.54. SMA-50 support at $220.65 is now floor.

Honest take: The Google delay spooked the market but the underlying custom ASIC TAM is massive. This is a legitimate buy-the-dip setup at SMA-50 with a clear technical anchor. The connectivity story is secular, not cyclical. Strong risk/reward here with SMA-50 as your defined stop.

GOLD (+11.2%) — $46.13 → $47.92 (+3.9% near-term) Thesis: Gold.com reported Q4 revenue nearly doubled to $5B with full-year revenue up 132% to $25.5B — record numbers. However, management flagged softer precious metals demand into FY2027 and the Tether partnership expansion is an unusual growth lever that needs monitoring. The RSI is an extreme 6.48 — this is one of the most oversold readings on the board, and the bounce from Fib 50% support at $45.95 is a technical rubber-band snap. Levels: Exit at Fib 38.2% $47.92. Bigger resistance at Fib 23.6% $50.37. Support at $45.95 Fib 50%.

Honest take: RSI of 6.48 is not normal — something drove this stock into deeply oversold territory recently, and the “softer demand” guidance is probably why. Today’s bounce looks like a dead-cat recovery to $47-48 rather than the start of a sustained rally. Scalp trade at best; avoid holding through FY2027 guidance risk.

ALAB (+9.8%) — $310.40 → $336.81 (+8.5% upside) Thesis: AI connectivity broadening is the same theme as MRVL but more concentrated in data center interconnects (Scorpio, Aries, Taurus product lines). 104.5% revenue growth is exceptional. The stock was down 24% in a month before today — this is a snapback bounce from the Fib 50% support zone at $291.64, which held. Volume at 1.9x confirms some conviction. Levels: Exit at Fib 38.2% $336.81. SMA-50 at $330.45 is near-term resistance first. Support: Fib 50% $291.64.

Honest take: Didn’t make the S&P 500 cut (the speculation ran but wasn’t confirmed), which removes a mechanical catalyst. The fundamental story — 104% growth in AI connectivity — is real. At 48x forward P/E vs. 17.5x peer median, you’re paying for it, but the PEG ratio on 100%+ growth is arguably reasonable. Bounce trade has merit if you use $291 as your stop.

TARS (+9.1%) — $90.78 → $100.21 (+10.4% upside) Thesis: XDEMVY posted $173.9M revenue with 69% growth — that’s a commercial launch on a strong trajectory. The Alkeus acquisition (Stargardt disease, ALK-001) puts TARS directly in competition with BLTE today — that’s why both stocks are moving together. TARS hit a fresh 6-month high with volume at 2x average. This is a real catalyst, not sympathy. Levels: Exit at Fib 1.272 extension $100.21. SMA-50 at $65.96 is deep support — shows how extended the stock is. Nearest meaningful support Fib 23.6% at $82.60.

Honest take: The XDEMVY commercial ramp is genuine. The Stargardt race adds a pipeline catalyst that’s separate from the core blepharitis business. However, the stock is up 26.5% on the week — respect the Fib 23.6% at $82.60 as your line in the sand.

Headlines to Watch

Nike Exits S&P 100, Replaced by SanDisk and Others — Mechanical selling in NKE (already near 6-month lows) and forced buying in SNDK; this is actionable today, not just interesting.
Cerebras Has a $25.4B Backlog, One OpenAI Agreement Behind Much of It — Concentration risk at 29x forward revenue is both the bull case and the single biggest vulnerability — monitor for any OpenAI relationship news.
Jensen Huang: 1-Gigawatt Facility Worth $50-60B — This comment directly validates the neocloud thesis behind NBIS and IREN; AI infrastructure spending is being quantified in ways that justify extreme capex.
Blowout Jobs Report (162K vs. 56K est.) Fans Rate Hike Fears — The strong labor market reduces probability of near-term Fed cuts; this is a headwind for high-multiple growth names and a tailwind for financials — watch the rate-sensitive end of your growth portfolio.
Bank of Japan Rate Move Warning — Japan hasn’t tightened like this since 1990; a BoJ hike unwinds the carry trade and directly pressures US growth stocks through yen appreciation — this is the macro risk that could derail today’s tech rally.
Snowflake Gives Back 5% Post-Earnings Surge — Classic sell-the-rip after a 17% guidance-driven pop; a reminder that even legitimate beats can be fully priced in overnight — relevant for how to handle SMTC, SIMO, and other recent runners.
Bloom Energy Up 52% Since Pelosi’s Buy; S&P 500 Addition Confirmed — The index inclusion is the actionable catalyst here; the Pelosi angle adds retail FOMO but the mechanical institutional buying through Sept. 21 is what matters.

Claude’s Top Picks

MRVL (+7.1% today, +3.2% week) — $223.55 → $259.54 (+16.1% upside) Valuation: No comp data provided but consensus puts MRVL at ~30-35x forward earnings — premium to peers but justified by custom ASIC growth pipeline. Upside: Bouncing off SMA-50 ($220.65) with a clear technical floor; raised FY guidance, Google ASIC TAM is a multi-year story that the market panic-discounted over one timing comment. Risk: Google revenue delayed to FY2029 means near-term earnings growth depends on Amazon/Microsoft custom silicon — any slowdown in hyperscaler capex kills the thesis.

BE (+7.4% today, +20.0% week) — $252.87 → $292.43 (+15.6% upside) Valuation: No specific comp data, but clean-energy infrastructure peers trade at significant premiums to FCF — BE’s S&P 500 inclusion suggests sufficient market cap and profitability to warrant institutional allocation. Upside: Hard-dated mechanical catalyst (Sept. 21 index inclusion) guarantees incremental buying from passive funds over the next two weeks; AI energy narrative provides fundamental staying power. Risk: Post-inclusion selloff is the classic pattern — stocks often dump on the actual rebalancing date as front-runners exit; have a plan to trim into Sept. 21.

NX (+22.2% today, +18.1% week) — $22.93 → $24.99 (+9.0% upside) Valuation: No comp data provided, but the EPS swing from -$6.04 to +$0.58 means trailing metrics are useless — on forward estimates post-recovery, building products peers typically trade 12-16x earnings. Upside: Massive profitability inflection (loss to profit), 5.5x average volume confirms institutional buying, and the stock just broke to a 52-week high on hard fundamental news — not hype. Risk: Soft new construction market and tariff impacts are ongoing headwinds management acknowledged — the stock needs continued margin execution to justify the gap-up; any guidance cut would give back this gain quickly.

ALAB (+9.8% today, +7.2% week) — $310.40 → $336.81 (+8.5% upside) Valuation: EXPENSIVE at 48.5x forward P/E vs. 17.5x peer median, but 104.5% revenue growth makes the PEG ratio close to 0.5x — optically expensive, fundamentally cheap relative to growth. Upside: Bounced from Fib 50% support at $291.64 after a 24% drawdown; AI connectivity is a secular theme and Scorpio/Aries/Taurus product demand is accelerating into data center buildouts. Risk: Missed S&P 500 inclusion removes a near-term mechanical bid; if the broader AI capex narrative cools even slightly, 48x forward P/E becomes very hard to defend.

SNDK (+11.9% today, +17.2% week) — $1,740.00 → $1,908.39 (+9.7% upside near-term) Valuation: Memory names traditionally trade on EV/EBITDA cycles; SNDK’s contracted-pricing model structurally improves earnings quality vs. commodity memory peers — warrants a premium. Upside: S&P 100 inclusion is a confirmed, non-discretionary institutional buying event; the “contracted pricing” structural story reduces cyclical risk that historically crushed memory stocks. Risk: Still 25% off 6-month highs, and the $1,908 Fib 23.6% retracement level is resistance from the prior selloff — the stock needs to clear that to sustain momentum into the $2,000+ range.

Avoid

GOLD — RSI of 6.48 signals extreme oversold conditions that usually mean something is fundamentally broken, not just temporarily unloved; the “softer demand” FY2027 guidance is a real headwind, and today’s bounce looks like a dead-cat recovery to the $47-48 Fib 38.2% level — not the start of a trend reversal.

BLTE — Already up 27.6% on the week and trading at 100x forward P/E vs. a 15.5x peer median — that’s 6x the peer valuation for a pre-revenue approval bet; the FDA priority review is priced in and then some, and with TARS now entering the Stargardt race, the competitive moat is narrowing. At the 6-month high with no technical ceiling overhead, risk/reward has flipped.

CBRS — Up 17.3% on the week at 165x forward P/E on a backlog that is 90%+ concentrated in a single customer relationship (OpenAI); any hint of that relationship changing, OpenAI building in-house, or a broader AI spending slowdown could cut this stock in half. The $25.4B backlog headline is impressive but the concentration risk makes this uninvestable for swing traders without a very tight stop at SMA-50 ($203).

WSB Sentiment Check

AGI — WSB says: BULLISH (80% bullish, 200 mentions, 7,199 upvotes) Claude says: PARTIALLY AGREE — AGI (Alamos Gold) is technically interesting, sitting just above the Fib 61.8% support at $36.70 with the SMA-50 below at $32.15 providing a strong floor, but gold demand facing headwinds (per GOLD’s earnings call) is a real fundamental concern. The 80% WSB bullishness at 7,199 upvotes feels like a gold/precious metals macro bet more than a company-specific thesis — that’s a thinner foundation than the conviction level implies.

NVDA — WSB says: MIXED (55% bullish, 31 mentions) Claude says: AGREE — Mixed is the right read. NVDA is only 2.6% off its 6-month high at $235.47, RSI is neutral at 50, and the AI trade is broadening beyond pure accelerators today (ALAB, MRVL outperforming NVDA). At $230 near the 6-month high, the risk/reward for new longs is compressed. The Fib 1.272 extension target is $254.64 — there’s upside but it’s not as asymmetric as the broadening plays.

NKE — WSB says: BULLISH (80% bullish, 31 mentions, 2,449 upvotes) Claude says: DISAGREE — NKE just got booted from the S&P 100 after nearly 18 years, is sitting at $38.40 near its 6-month low of $38.04, and the Fib structure shows all meaningful support levels ($45-52) are above current price — meaning those are now resistance, not support. The stock is in genuine structural decline. WSB’s 80% bullishness reads as “it’s so beaten up it must bounce” — that logic has destroyed accounts in value traps. Wait for a confirmed base, not a falling knife.

MU — WSB says: MIXED (55% bullish, 26 mentions) Claude says: AGREE — Mixed is fair. MU at $1,016 is at its 6-month high with Fib 23.6% support at $1,003 right below — it’s extended but just barely. The memory cycle and AI storage demand (reinforced by the SNDK story today) are genuine tailwinds. However, a 162K jobs report reducing Fed cut probability means high-multiple semis face a valuation headwind. Not a strong conviction trade in either direction right now.

NOW — WSB says: BULLISH (80% bullish, 25 mentions, 1,697 upvotes) Claude says: PARTIALLY AGREE — ServiceNow at $141.26 is approaching its 6-month high of $147.99, with the SMA-50 way below at $117.02 — the stock has had a strong run. WSB’s bullishness is directionally right (AI platform demand is real, guidance was strong) but the stock is 95% of the way to its 6-month high with limited upside to the 1.272 extension at $165.67. Chasing here is late — better entry would be on a pullback to $132.65 (Fib 23.6%). Agree with the thesis, disagree with the timing.

Earnings Scorecard

SAIL (SailPoint) — REPORTED | EPS: -$0.25 | Stock: -2.9% Muted selloff on a loss quarter — the -2.9% reaction suggests the market expected weak numbers; at a $20.06 analyst target, this looks like a hold-don’t-add situation unless the Q2 call provides operating leverage visibility.

DSGX (Descartes Systems) — REPORTED | EPS: $2.01 | Stock: -2.2% Profitable quarter met with selling — classic “sell the news” after what may have been a pre-earnings run; at a $100.23 analyst target, the -2.2% dip may represent a buy-the-dip opportunity for a quality logistics software name, but confirm whether guidance was maintained.

AEO (American Eagle) — REPORTED | EPS: $1.59 | Stock: +2.2% Modest positive reaction to a profitable print — with a $19.70 analyst target and current price likely near that range, the reaction looks appropriately sized; neither a rip to sell nor a dip to buy aggressively.

AVAV (AeroVironment) — REPORTED | EPS: -$5.40 | Stock: -1.7% A large EPS loss met with a relatively contained -1.7% move — defense names often carry lumpy quarterly results, and the $225.77 analyst target suggests this is priced for recovery; the muted reaction to a big miss suggests the Street expected it.

CNM (Core & Main) — REPORTED | EPS: $2.36 | Stock: +0.8% Quiet beat, quiet reaction — at a $59.43 analyst target, CNM is likely already near fair value; infrastructure exposure is solid but this isn’t an exciting catalyst.

KR (Kroger) — REPORTED | EPS: $1.71 | Stock: +0.1% Flat reaction to an in-line grocery print — $70.27 analyst target suggests meaningful upside from current levels but the catalyst for re-rating isn’t visible in this quarter; defensive hold, not an aggressive buy.

This brief is for informational purposes only and does not constitute investment advice. All prices and targets are based on data as of September 7, 2026. Past performance of technical levels is not indicative of future results.